NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Devices · USD

Medtronic plc. (MDT) Stock Analysis

Medtronic plc. (MDT) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

MDT

$93.03

−$1.60 (−1.69%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MDT with… →

MDT Key Statistics

As of Oct 21, 2026
Trading
Open
$93.25
Previous Close
$94.63
Day's Range
92.71–95.30
52-Week Range
73.31–106.33
Volume
11.51M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.57
Valuation
Market Cap
$119.00B
P/E Ratio
22.86
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
14.52
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.70
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.17
EPS (ttm)Profit attributable to each share over the last twelve months.
4.07
Financials (FY)
Revenue (FY)
$36.36B+8.43%
Net Income (FY)
$4.80B+2.98%
Profit marginThe share of revenue left as profit after all costs and taxes.
13.93%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.28B
1-Year Return
+0.30%
Dividend and dates
Dividend
$2.88+3.04%
Ex-Dividend Date
September 25, 2026
Earnings Date
November 17, 2026estimated
Avg Volume
16.29M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, MDT closed at $93.03, +0.30% over 1 year.

Medtronic plc. (MDT) has a market capitalization of $119.00B.

In fiscal 2025, MDT reported revenue of $36.36B.

MDT Stock Return by Calendar Year

Medtronic plc. (MDT) 10-year return: what $10,000 became

1 year
$10,000 $10,030
+0.30%
5 years
$10,000 $8,974
−10.26%
10 years
$10,000 $14,441
+44.41%

If you had invested $10,000 in Medtronic plc. (MDT) 10 years ago, at the close on October 21, 2016, it would have been worth $14,441 at the close on October 21, 2026: +44.41% in total, +3.74% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−0.67%
2025+24.05%
2024+0.28%
2023+9.58%
2022−22.55%
2021−9.79%
2020+5.70%
2019+27.34%
2018+14.60%
2017+15.90%
2016 (partial year)−17.86%

As of October 21, 2026.

MDT Revenue and Earnings by Fiscal Year

FY ends April
Fiscal yearRevenueNet incomeNet margin
2025$36.36B$4.80B13.2%
2024$33.54B$4.66B13.9%
2023$32.36B$3.68B11.4%
2022$31.23B$3.76B12.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$36.36B$23.64B$6.83B$4.80B13.2%
2024$33.54B$21.91B$6.54B$4.66B13.9%
2023$32.36B$21.15B$5.52B$3.68B11.4%
2022$31.23B$20.51B$5.83B$3.76B12.0%

Annual figures as reported, in the company's reporting currency. As of April 30, 2026.

MDT Dividend History

$2.83+1.4% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$2.153—
2025$2.834+1.4%
2024$2.794+1.5%
2023$2.754+3.0%
YearDividends per sharePaymentsChange
2026 (partial year)$2.153—
2025$2.834+1.4%
2024$2.794+1.5%
2023$2.754+3.0%
2022$2.674+8.1%
2021$2.474+8.3%
2020$2.284+7.5%
2019$2.124+45.2%
2018$1.463−19.3%
2017$1.814+320.9%
2016$0.431—

Most recent payment: $0.72 per share, ex-dividend September 25, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

MDT Valuation vs Medical Devices Median

Median of 145 stocks
MetricMDTMedical Devices medianvs median
P/E22.8627.0816% below
P/S ratio3.172.5325% above
Profit margin13.93%−14.78%28.7 pts above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Medtronic plc. (MDT) is capitalised at $119.00B on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 95,000 employees.

The most recent close on file for MDT is $93.03, dated October 21, 2026. That is −$1.60 (−1.69%) against the previous close. The 52-week range on file runs from $73.31 to $106.33. The latest close sits 26.9% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $36.36B. Against the prior fiscal year total of $33.54B, that is a change of +8.43%. Net income for the same year was $4.80B. That is +2.98% against the prior fiscal year. The reported profit margin is 13.93%. That is 28.7 percentage points above the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to 4.07.

Across the 4 fiscal years on file, revenue moves from $31.23B in 2022 to $36.36B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

MDT trades at a trailing price-to-earnings ratio of 22.86. That is 15.58% below the Medical Devices median of 27.08. On forward earnings the ratio is 14.52. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.7. The price-to-sales ratio is 3.17. On price-to-sales that is 25.3% above the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

Beta against the wider market is reported at 0.57. Daily returns over the trailing 10 years annualize to a volatility of 23.64%. Over the trailing twelve months the total return is +0.30%. Across 10 years the annualized return works out at +3.74%.

Growth & Income

Shareholders receive a dividend, yielding 3.04% on the latest price. That is 1.9 percentage points above the Medical Devices median yield of 1.15%. At the indicated rate that is $2.88 a share a year. The ex-dividend date on file is September 25, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $2.15 a share. The year before, 2025, totalled $2.83 a share.

So far in 2026 the total return is −0.67%. Across the complete calendar years on file, 2019 returned +27.34% and 2022 returned −22.55%. Of the 9 complete calendar years on file, 7 finished higher.

Peer Comparison

Medtronic plc. (MDT) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Medtronic plc. MDT $119.00B 22.9
Abbott Laboratories ABT $173.92B 32.4
Stryker Corporation SYK $114.15B 30.8
Boston Scientific Corporation BSX $64.33B 18.0

The Medical Devices industry average P/E ratio is 27.1x. Medtronic plc. trades at a P/E of 22.9.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B

 DXCM

DexCom, Inc.

$30.29B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Medtronic plc.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Visit website →